More
    Guided Solutions - Connecting Talent With Innovation/div>

    Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery

    With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that...

    EchoNous Secures $60 Million in Funding from Kennedy Lewis Investment Management

    EchoNous, the leader in portable AI-guided ultrasound tools and software, announced it has raised $60 million in funding from Kennedy Lewis Investment Management (“Kennedy...

    Viz.ai sets its sights across the pond with CE mark for stroke-detecting AI

    With a recent influx of more than $70 million in a series C financing and, now, a shiny new CE mark for its stroke-spotting...

    Surgical robotics company CMR raises $600M

    UK-based robotics company CMR Surgical this morning announced a $600 million Series D. This latest round, led by SoftBank’s Vision Fund 2 and co-led by...

    Indago Rebrands to Lazurite, Raises Funding

    Indago, a medical device and technology company, announces the successful close of its $10 million convertible note round of financing. The funds will be...

    Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

    Largest-ever private funding round for a dialysis device company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology leader delivering on its vision...

    AI drug discovery start-up Insilico raises more than $255m

    Hong Kong-based company Insilico Medicine, which uses artificial intelligence (AI) for drug discovery and development, has raised $255 million in a new funding round...

    Patient Monitoring Provider Spiras Health Receives $14M Funding

    National Value-based Provider of In-Home Specialty Care Services Receives Capital to Expand Partnerships; Reach Most Costly and Complex Patients Spiras Health, a provider of in-home...

    Cleerly Launches with $43 Million Series B to Provide a New Standard of Care for the Leading Cause of Death – Heart Disease

    Resulting from More than a Decade of Clinical Research, Company Unveils Non-Invasive Approach to Identify, and New Care Pathways to Address Heart Disease Using...

    Latest articles